Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Palo Alto, CA

68 studies for Prostate Cancer are recruiting at 147 sites within 50 miles of Palo Alto, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Palo Alto.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Palo Alto

Showing the 50 nearest of 68 studies.
  1. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Stanford Cancer Institute Palo Alto (Palo Alto, CA); Kaiser Permanente-Redwood City (Redwood City, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  2. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Stanford Cancer Institute Palo Alto (Palo Alto, CA); VA Palo Alto Health Care System (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  3. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Stanford University (Palo Alto, CA); VA Palo Alto Health Care System (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford Cancer Institute, Stanford University (Palo Alto, CA); University of California San Francisco, Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford Cancer Center ( Site 0036) (Palo Alto, CA); San Francisco VA Health Care System ( Site 0093) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Stanford University Medical Center (Palo Alto, CA); VA Palo Alto Health Care System (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

    NCT05125016

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Stanford University Medical Center - Blake Wilbur Drive (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    NCT05997615

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Investigational Site Number: 403 (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

    NCT06067841

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Stanford Cancer Center (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    NCT06136624

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Cancer Center ( Site 0036) (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

    NCT06531499

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Stanford University (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Stanford University Medical Center (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Stanford Cancer Center ( Site 0046) (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Prostate Active Surveillance Study

    NCT00756665

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: Stanford University (Stanford, CA); University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Stanford, CA); Massive Bio SYNERGY-AI site (San Francisco, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

    NCT04868604

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

    NCT06056830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Stanford University Medical Center (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Study With [225Ac]Ac-FL-020 in mCRPC Participants

    NCT06492122

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Stanford (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    NCT07114601

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University Medical Center (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Sacral Neuromodulation for Male Overactive Bladder (MOAB)

    NCT06511141

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: USNC (Mountain View, CA); University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Kaiser Permanente- Marshall Medical Offices (Redwood City, CA); Kaiser Permanente-Fremont (Fremont, CA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  22. Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

    NCT06235697

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Kaiser Permanente- Marshall Medical Offices (Redwood City, CA); Kaiser Permanente-Fremont (Fremont, CA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  23. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Kaiser Permanente-Fremont (Fremont, CA); Kaiser Permanente Medical Center - Santa Clara (Santa Clara, CA)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  24. Distance-Based Exercise to Preserve Function and Prevent Disability

    NCT07059884

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Fremont (Fremont, CA); Kaiser Permanente Medical Center - Santa Clara (Santa Clara, CA)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  25. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Kaiser Permanente-Division of Research (Pleasanton, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

    NCT04763980

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: University of California San Francisco (San Francisco, CA); Zuckerberg San Francisco General Hospital (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  27. Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

    NCT02526368

    • Early Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

    NCT03821246

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

    NCT03933670

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT04221542

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

    NCT04472338

    • Observational
    • Ages 40 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Medical Center at Mission Bay (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Precision-Based Genomics in Prostate Cancer

    NCT04706663

    • Observational
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

    NCT04986423

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

    NCT05113537

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer

    NCT05396872

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: San Francisco Veterans Affairs Medical Center (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

    NCT05417594

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Mechanisms of Resistance to PSMA Radioligand Therapy

    NCT05435495

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Two-fraction HDR Monotherapy for Localized Prostate Cancer

    NCT05665738

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

    NCT05766371

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

    NCT05851365

    • Early Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. 64Cu-GRIP B in Patients With Advanced Malignancies

    NCT05888532

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

    NCT06171139

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

    NCT06228053

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

    NCT06257693

    • Phase 1
    • Ages 21 years and older
    • Sex: Male

    Nearest site: University of California San Francisco Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

    NCT06391034

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

    NCT06526299

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

    NCT06613100

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.